Disseminated Intravascular Coagulation and Immune Hemolytic Anemia, Possibly Evans Syndrome, After Oxaliplatin and Bevacizumab Infusion for Metastatic Colon Adenocarcinoma: A Case Report and Literature Review

Oxaliplatin is widely used in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX) as the first-line treatment for metastatic colorectal cancer.1-3 The combination of oxaliplatin with 5-fluorouracil3 or capecitabine1,2 significantly improves the response rate and progression-free survival. Common side effects of oxaliplatin are sensory neuropathy (observed in approximately 80% patients who receive XELOX), neutropenia, nausea, and...